Sterilization and disinfection are essential components of infection control procedures. New technologies like E-beam and gamma are poised to garner strong market shares in the future, due to their greater product compatibility and low prices. These technologies have been beneficial for medical packaging, food irradiation, medical disposables, and microbiological equipment sterilization.
In this report, the market is segmented by products, end users, and regions. The infection-control market is broadly split into two product segments, namely, sterilization and disinfection. The disinfection market is further divided into disinfectors, disinfectants, endoscope preprocessor, medical non-wovens, and disinfectant wipes. Medical non-wovens accounted for the largest share of the disinfection market in 2014. The endoscope reprocessing market is the fastest-growing segment during the forecast period. The endoscope reprocessing market is anticipated to show healthy growth in upcoming years due to continued instrument development, and increase in minimally invasive surgeries. With the rising preference for single-use technology products like medical non-wovens and face masks, the disinfection market is expected to foresee strong growth, especially in developing countries.
The sterilization market is segmented into heat sterilization, low temperature sterilization, and filtration sterilization. Heat sterilization accounted for the largest share of the sterilization market in 2014. The low temperature sterilization market is the fastest-growing segment during the forecast period. Low temperature sterilization is fast and non-toxic, as compared to the other sterilization technologies available; it also has greater material compatibility.
On the basis of end user, the infection control market is segmented into hospitals, life sciences, medical device companies, pharmaceutical companies, and others. The hospital segment accounted for the largest share of the infection control market, by end user, in 2014 owing to the extensive use of infection control technologies in hospitals.
The global infection control market is expected to grow at a CAGR of 6%–7% during the forecast period (2015 to 2020). In 2014, North America commanded the largest share of the global infection control market, followed by Europe, Asia-Pacific, and RoW. Developed geographies like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market, which is expected to witness the fastest growth during the forecast period. Growth in the Asia-Pacific market is largely driven by the rise in health awareness, growth of aging population, increase in number of surgical procedures, and growth in per capita income.
Some of the major players in the infection control market are 3M Company(U.S.), Getinge Group(Sweden), STERIS Corporation(U.S.), Medivators (U.S.), Advanced Sterilization Products Services Inc. (U.S.), Belimed AG (Switzerland), Kimberly-Clark Corporation (U.S.), Sterigenics International Inc.(U.S.), MÜNCHENER MEDIZIN MECHANIK GMBH (MMM) (Germany), and Synergy Health (U.K.).